Toronto, Canada

Ganna Posternak

USPTO Granted Patents = 1 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ganna Posternak: Innovator in Cancer Research

Introduction

Ganna Posternak is a prominent inventor based in Toronto, Canada. She has made significant contributions to the field of cancer research, particularly through her innovative work on proteolysis modulators.

Latest Patents

Ganna holds a patent for "Amide-based proteolysis modulators of B-rapidly accelerated fibrosarcoma (BRAF) and associated uses." This patent relates to novel compounds that contain an E3 ubiquitin ligase binding moiety linked to a Raf protein kinase binding moiety. The application also includes methods and uses of these compounds, specifically for inhibiting and/or degrading the V600E mutant B-Raf. Ganna's work in this area is crucial for developing new therapeutic strategies against certain types of cancer.

Career Highlights

Ganna Posternak is affiliated with the Ontario Institute for Cancer Research and Sinai Health System. Her role in these institutions allows her to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Ganna has worked alongside notable colleagues such as Frank Sicheri and Gennady Poda. These collaborations enhance the research environment and foster innovation in cancer treatment.

Conclusion

Ganna Posternak is a dedicated inventor whose work is paving the way for advancements in cancer therapies. Her innovative approach and commitment to research are making a significant impact in the medical field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…